The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41

Collection

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

Source

Risk warning

Real-time Records of Institutional Crypto Holdings and Capital Operations

Recently, stablecoin concept stocks have continued to strengthen, with multiple listed companies establishing reserves of crypto assets. Stocks of crypto companies are becoming a special "crypto hotspot": traditional market investors are beginning to pay attention to companies in the crypto industry, while people in the crypto circle view the price changes of crypto stocks as one of the indicators of market fluctuations. This topic will continue to focus on the dynamics of related projects, institutional movements, market performance, and the strategic logic behind them, gaining insights into the development path of this wave of integration between crypto and equity.

Topic or theme